The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

RECOMMENDED FORMULA: This formula includes lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E to exactly match the nutrient formula recommended by the AMD experts at the National Eye ...

We highly recommend the PreserVision AREDS 2 Eye Vitamin & Mineral Supplement to anyone looking for an eye health supplement. We found that the Focus Select AREDS2 Based Eye Vitamin-Mineral ...

RECOMMENDED FORMULA: This formula includes lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E to exactly match the nutrient formula recommended by the AMD experts at the National Eye ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

Investing.com -- Bausch + Lomb (NYSE:BLCO) is exploring a potential ... This has caused its market value to fall to $2.2 billion, raising concerns about the company's financial stability.

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third ...

1,2* VAUGHAN, Ontario, May 29, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to ...